Alternative RNA splicing in expression of the glutathione synthetase gene in human cells

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 2105-2109

  Uchida, Marie ^a   Sugaya, Maki ^a   Kanamaru, Taichi ^a   Hisatomi, Hisashi ^a  

^a SEIKEI UNIVERSITY   (Japan)

Author keywords

Alternative splicing; Glutathione synthetase; Oxidative stress

Indexed keywords

GLUTATHIONE SYNTHASE; MESSENGER RNA; ISOENZYME;

ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD; CANCER CELL CULTURE; COLON; CONTROLLED STUDY; ENZYME REGULATION; EXON; GENE DELETION; GENE EXPRESSION; HEART; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; KIDNEY; LIVER; LUNG; NUCLEOTIDE SEQUENCE; PLACENTA; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPLEEN; UTERUS; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; TUMOR CELL LINE;

MAMMALIA;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE SYNTHASE; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MUTATION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 77953169016     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9675-3     Document Type: Article

References (28)

1. Mohler DN, Majerus PW, Minnich V, Hess CE, Garrick MD (1970) Glutathione synthetase deficiency as a cause of hereditary hemolytic disease. N Engl J Med 283:1253-1257
2. Al-Jishi E, Meyer BF, Rashed MS, Al-Essa M, Al-Hamed MH, Sakati N, Sanjad S, Ozand PT, Kambouris M (1999) Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency. Clin Genet 55(6):444-449
3. Oort M, Loos JA, Prins HK (1961) Hereditary absence of reduced glutathione in the erythrocytes-a new clinical and biochemical entity? (Preliminary communication). Vox Sang 6:370-373. doi: 10.1111/j.1423-0410.1961. tb03178.x
4. Prins HK, Oort M, Loos JA, Zurcher C, Beckers T (1966) Congenital nonspherocytic hemolytic anemia, associated with glutathione deficiency of the erythrocytes. Hematologic, biochemical and genetic studies. Blood 27:145-166
5. Spielberg SP, Garrick MD, Corash LM, Butler JB, Tietze F, Rogers L, Schulman JD (1978) Biochemical heterogeneity in glutathione synthetase deficiency. J Clin Invest 61:1417-1420. doi:10.1172/JCI109060
6. Ristoff E, Mayatepek E, Larsson A (2001) Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr 139:79-84. doi:10.1067/mpd.2001.114480 (Pubitemid 32613991)
7. Beutler E, Gelbart T, Pegelow C (1986) Erythrocyte glutathione synthetase deficiency leads not only to glutathione but also to glutathione-S-transferase deficiency. J Clin Invest 77:38-41. doi: 10.1172/JCI112298
8. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52:711-760. doi:10.1146/annurev.bi.52.070183.003431
9. Uhlig S, Wendel A (1992) The physiological consequences of glutathione variations. Life Sci 51:1083-1094. doi:10.1016/0024-3205 (92)90509-N
10. ShiZ-Z,HabibGM,RheadWJ,GahlWA,HeX, Sazer S,Lieberman MW (1996) Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet 14:361-365. doi:10.1038/ng1196-361
11. Vives Corrons J-L, Alvarez R, Pujades A, Zarza R, Oliva E, Lasheras G, Callis M, Ribes A, Gelbart T, Beutler E (2001) Hereditary non-spherocytic haemolytic anaemia due to red blood cell glutathione synthetase deficiency in four unrelated patients from Spain: Clinical and molecular studies. Br J Haematol 112:475-482. doi:10.1046/j.1365-2141.2001.02526.x (Pubitemid 32183497)
12. Dahl N, Pigg M, Ristoff E, Gali R, Carlsson B, Mannervik B, Larsson A, Board P (1997) Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5- oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet 6:1147-1152. doi:10.1093/hmg/6.7.1147 (Pubitemid 27308401)
13. Njalsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S (2005) Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 116:384-389. doi:10.1007/s00439-005-1255-6 (Pubitemid 40521115)
14. Webb GC, Vaska VL, Gali RR, Ford JH, Board PG (1995) The gene encoding human glutathione synthetase (GSS) maps to the long arm of chromosome 20 at band 11.2. Genomics 30:617-619. doi:10.1006/geno.1995.1287 (Pubitemid 26038561)
15. Belli R, Amerio P, Brunetti L, Orlando G, Toto P, Proietto G, Vacca M, Tulli A (2005) Elevated 8-isoprostane levels in basal cell carcinoma and in UVA irradiated skin. Int J Immunopathol Pharmacol 18:497-502
16. Schwedhelm E, Boger RH (2003) Application of gas chromatography- mass spectrometry for analysis of isoprostanes: Their role in cardiovascular disease. Clin Chem Lab Med 41:1552-1561. doi: 10.1515/CCLM.2003.238 (Pubitemid 38063066)
17. Nagao K, Kohno N, Wakita K, Hikiji K, Hirata H, Hisatomi H (2003) Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer. Oncol Rep 10:305-308
18. Hanke J, Brett D, Zastrow I, Aydin A, Delbruck S, Lehmann G, Luft F, Reich J, Bork P (1999) Alternative splicing of human genes: More the rule than the exception? Trends Genet 15:389-390. doi:10.1016/S0168-9525(99)01830-2 (Pubitemid 29469066)
19. Mironov AA, Fickett JW, Gelfland MS (1999) Frequent alternative splicing of human genes. Genome Res 9:1288-1293. doi: 10.1101/gr.9.12.1288 (Pubitemid 30042512)
20. Stallings-Mann ML, Ludwiczak RL, Klinger KW, Rottman F (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci USA 93:12394-12399. doi:10.1073/pnas. 93.22.12394
21. Liu W, Qian C, Francke U (1997) Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 16: 328-329. doi:10.1038/ng0897- 328
22. Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8:1893-1990. doi: 10.1093/hmg/8.10.1893 (Pubitemid 29458667)
23. Lykke-Andersen J, Shu MD, Steitz JA (2000) Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 103:1121-1131. doi:10.1016/ S0092-8674(00)00214-2
24. Watakabe A, Tanaka K, Shimura Y (1993) The role of exon sequences in splice site selection. Genes Dev 7:407-418. doi: 10.1101/gad.7.3.407
25. Cartegni L, Krainer AR (2002) Disruption of an SF2/ASFdependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377-384. doi:10.1038/ng854
26. Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58
27. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571. doi:10.1093/nar/gkg616 (Pubitemid 37442199)
28. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15:2490-2508. doi:10.1093/hmg/ddl171 (Pubitemid 44288702)